anmelden
OMX Nordic 40
2.621,38
PKT
+17,53
PKT
+0,67
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.11.18 | Nokia Outperform | Credit Suisse Group | |
| 13.11.18 | Fortum Sell | Goldman Sachs Group Inc. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.11.18 | ABB (Asea Brown Boveri) Hold | Baader Bank | |
| 06.11.18 | Fortum buy | Société Générale Group S.A. (SG) | |
| 06.11.18 | Novo Nordisk Reduce | HSBC | |
| 05.11.18 | Novo Nordisk buy | UBS AG | |
| 02.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.18 | Novo Nordisk Hold | CFRA | |
| 02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 02.11.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 01.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 31.10.18 | Nokia buy | Deutsche Bank AG | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.10.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 30.10.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.10.18 | Volvo (B) Sell | UBS AG | |
| 29.10.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 29.10.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 29.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.10.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 26.10.18 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 26.10.18 | Nokia buy | UBS AG | |
| 26.10.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 26.10.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 26.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.18 | Nokia Outperform | Credit Suisse Group | |
| 26.10.18 | Nokia Neutral | Goldman Sachs Group Inc. |